A lot of people have been asking my opinion on when a concise generic biologic regulatory pathway will emerge in […]
When will the U.S. develop concise generic biologic rules? Read Post »
I recently had the opportunity to conduct a brief interview with Mireille Gingras, Ph.D. President and CEO of HUYA Bioscience
Guest content from Turner Investment Partners‘ Heather Flick McMeekin, Frank Sustersic, Vijay Shankaran, and Theresa Hoang: Contract research helps keep
Contract research helps keep drug pipeline flowing Read Post »
Building Biotechnology: Business, Regulations, Patents, Law, Politics, Science 460 pages Hardcover: 978-09734676-5-9 Softcover: 978-09734676-6-6 Third Edition August, 2008 Homepage The
Building Biotechnology 3rd Edition now available Read Post »
Here’s a slideshow of a talk I recently gave at the Johns Hopkins biotechnology MS/MBA program. The purpose is to
Beyond the Business Plan: Managing unexpected risk in biotechnology business development Read Post »
Roche has floated an offer to acquire Genentech, a move which has raised a flurry of questions about the sustainability
Roche and Genentech's mating dance — This isn't the first time Read Post »
Roche has floated an offer to acquire Genentech, a move which has raised a flurry of questions about the sustainability
Roche and Genentech’s mating dance — This isn’t the first time Read Post »
Guest content from Christopher Starr: After years of confusion and neglect, translational research is now becoming institutionalized. Citing the barriers
Background: The Clinical and Translational Science Awards Consortium (CTSA program) Read Post »
Guest content from Nicolaj H. Nielsen, managing director of Biostrat. A case-study on the recent licensing-deal between Myriad and Lundbeck:
Reach a targeted audience with BiotechBlog. Advertising opportunities are available on BiotechBlog. BiotechBlog is syndicated by BlogBurst, which means that
Get new actionable insights and updates from BiotechBlog
